Once-Daily Budesonide Inhalation Powder (Pulmicort Turbuhaler®) is Effective and Safe in Adults Previously Treated with Inhaled Corticosteroids

REFERENCES

• Haahtela T. Airway Remodelling Takes Place in Asthma—What Are the Clinical Implications?. Clin. Exp. Allergy 1997; 27: 351–353
   PubMed Web of Science ®Google Scholar
• Jagoda A., Shepherd S.M., Spevitz A., Joseph M.M. Refractory Asthma, Part I: Epidemiology, Pathophysiology, Pharmacologic Interventions. Ann. Emerg. Med. 1997; 29: 262–274
   Google Scholar
• National Asthma Education and Prevention Program: Guidelines for the Diagnosis and Management of Asthma. Publication No. 97-4051. Bethesda (MD), National Heart, Lung, and Blood Institute, National Institutes of Health, 1997
   Google Scholar
• Barnes P.J. Inhaled Glucocorticoids for Asthma. N. Engl. J. Med. 1995; 332: 868–875
   PubMed Web of Science ®Google Scholar
• Brogden R.N., McTavish D. Budesonide. An Updated Review of Its Pharmacological Properties, and Therapeutic Efficacy in Asthma and Rhinitis. Drugs 1992; 44: 375–407
   PubMed Web of Science ®Google Scholar
• Busse W.W., Chervinsky P., Condemi J., Lumry W.R., Petty T.L., Rennard S., Townley R.G. Budesonide Delivered by Turbuhaler Is Effective in a Dose-Dependent Fashion When Used in the Treatment of Adult Patients with Chronic Asthma. J. Allergy Clin. Immunol. 1998; 101: 457–463
   PubMed Web of Science ®Google Scholar
• Kemp J., Wanderer A.A., Ramsdell J., Southern D.L., Weiss S., Aaronson D., Grossman J. Rapid Onset of Control with Budesonide Turbuhaler in Patients with Mild to Moderate Asthma. Ann. Allergy Asthma Immunol. 1999; 82: 463–471
   PubMed Web of Science ®Google Scholar
• Nelson H.S., Bernstein I.L., Fink J., Edwards T.B., Spector S.L., Storms W.W., Tashkin D.P. Oral Glucocorticosteroid-Sparing Effect of Budesonide Administered by Turbuhaler: A Double-Blind, Placebo-Controlled Study in Adults with Moderate-to-Severe Chronic Asthma. Chest 1998; 113: 1264–1271
   PubMedGoogle Scholar
• Thorsson L., Edsbäcker S., Conradson T.-B. Lung Deposition of Budesonide from Turbuhaler® is Twice That from a Pressurized Metered-Dose Inhaler P-MDI. Eur. Respir. J. 1994; 7: 1839–1844
   PubMed Web of Science ®Google Scholar
• Agertoft L., Pedersen S. Importance of the Inhalation Device on the Effect of Budesonide. Arch. Dis. Child. 1993; 69: 130–133
   PubMed Web of Science ®Google Scholar
• Shapiro G., Bronsky E.A., Laforce C.F., Mendelson L., Pearlman D., Schwartz R.H., Szefler S.J. Dose-Related Efficacy of Budesonide Administered via a Dry Powder Inhaler in the Treatment of Children with Moderate to Severe Persistent Asthma. J. Pediatr. 1998; 132: 976–982
   PubMed Web of Science ®Google Scholar
• Horn C.R., Clark T.J.H., Cochrane G.M. Compliance with Inhaled Therapy and Morbidity from Asthma. Respir. Med. 1990; 84: 67–70
   PubMed Web of Science ®Google Scholar
• Mawhinney H., Spector S.L., Kinsman R.A., Siegel S.C., Rachelefsky G.S., Katz R.M., Rohr A.S. Compliance in Clinical Trials of Two Nonbronchodilator, Antiasthma Medications. Ann. Allergy 1991; 66: 294–299
   PubMedGoogle Scholar
• Cochrane G.M. Compliance and Outcomes in Patients with Asthma. Drugs 1996; 52(suppl 6)12–19
   PubMed Web of Science ®Google Scholar
• Bittar N. Maintaining Long-Term Control of Blood Pressure: The Role of Improved Compliance. Clin. Cardiol. 1995; 18: III12–III16
   Google Scholar
• Jordan T.J., Reichman L.B. Once-Daily Versus Twice-Daily Dosing of Theophylline. A Decision Analysis Approach to Evaluating Theophylline Blood Levels and Compliance. Am. Rev. Respir. Dis. 1989; 140: 1573–1577
   PubMedGoogle Scholar
• Mann M., Eliasson O., Patel K., ZuWallack R.L. A Comparison of the Effects of bid and qid Dosing on Compliance with Inhaled Flunisolide. Chest 1992; 101: 496–499
   PubMed Web of Science ®Google Scholar
• American Thoracic Society. Standards for the Diagnosis and Care of Patients with Chronic Obstructive Pulmonary Diseases (COPD) and Asthma. Am. Rev. Respir. Dis. 1987; 136: 225–244
   PubMed Web of Science ®Google Scholar
• Juniper E.F., Guyatt G.H., Epstein R.S., Ferrie P.J., Jaeschke R., Hiller T.K. Evaluation of Impairment of Health Related Quality of Life in Asthma: Development of a Questionnaire for Use in Clinical Trials. Thorax 1992; 47: 76–83
   PubMed Web of Science ®Google Scholar
• Juniper E.F., Guyatt G.H., Willan A., Griffith L.E. Determining a Minimal Important Change in a Disease-Specific Quality of Life Questionnaire. J. Clin. Epidemiol. 1994; 47: 81–87
   PubMed Web of Science ®Google Scholar
• Guyatt G.H., Juniper E.F., Walter S.D., Griffith L.E., Goldstein R.S. Interpreting Treatment Effects in Randomized Trials. BMJ 1998; 316: 690–693
   PubMed Web of Science ®Google Scholar
• Redelmeier D.A., Guyatt G.H., Goldstein R.S. Assessing the Minimal Important Difference in Symptoms: A Comparison of Two Techniques. J. Clin. Epidemiol. 1996; 49: 1215–1219
   PubMed Web of Science ®Google Scholar
• McFadden E.R., Casale T.B., Edwards T.B., Kemp J.P., Metzger W.J., Nelson H.S., Storms W.W. Administration of Budesonide Once-a-Day via Turbuhaler® to Subjects with Stable Asthma. J. Allergy Asthma Immunol. 1999; 104: 46–52
   Google Scholar
• Campbell L.M., Bodalia B., Gogbashian C.A., Gunn S.D., Humphreys P.J. on behalf of the PETITE research group. Once-Daily Budesonide: 400 Micrograms Once Daily Is as Effective as 200 Micrograms Twice Daily in Controlling Childhood Asthma. PETITE Research Group. Int. J. Clin. Pract. 1998; 52: 213–219
   PubMed Web of Science ®Google Scholar
• Chisholm S.L., Dekker F.W., Kklnuistingh Neven A., Petri H. Once-Daily Budesonide in Mild Asthma. Respir. Med. 1998; 92: 421–425
   PubMed Web of Science ®Google Scholar
• Bender B., Milgrom H., Rand C., Ackerson L. Psychological Factors Associated with Medication Nonadherence in Asthmatic Children. J. Asthma 1998; 35: 347–353
   PubMed Web of Science ®Google Scholar
• Bender B., Milgrom H., Rand C. Nonadherence in Asthmatic Patients: Is There a Solution to the Problem?. Ann. Allergy Asthma Immunol. 1997; 79: 177–186
   PubMed Web of Science ®Google Scholar
• Coutts J.A.P., Gibson N.A., Paton J.Y. Measuring Compliance with Inhaled Medication in Asthma. Arch. Dis. Child 1992; 67: 332–333
   PubMed Web of Science ®Google Scholar
• Goldstein M., Banov C., Liljas B., Walton-Bowen K., Hampel F. Once Daily Budesonide (Pulmicort Turbuhaler®) Improves Quality of Life in Adult Asthmatics Previously Treated with Inhaled Corticosteroids. Ann. Allergy Asthma Immunol. 2000; 84: 161, (Abstract)
   Google Scholar